Atrial fibrillation (AFib), a quivering of the heart's upper chambers, is the most prevalent cardiac arrhythmia globally. The market for diagnosing, treating, and managing AFib is keeping pace with this rising health concern, estimated to reach a value of USD 20.93 billion by 2028. This growth is driven by several key factors: An Aging Population: As the global population ages, the risk...